🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Percutaneous Ultrasound-guided Neuromodulation to Improve Gait Rehabilitation in Patients Who Have Suffered a Stroke.

RecruitingNAAges 18 Years - 70 YearsAllAlejandro Martín García
NCT07196878 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if percutaneous ultrasound-guided neuromodulation (NMP-e) can improve gait rehabilitation in adults who have suffered a stroke. The main questions it aims to answer are: * Does NMP-e improve walking speed in stroke survivors? * Does NMP-e enhance muscle strength, functional mobility, reduce spasticity, improve balance, and increase health-related quality of life? Researchers will compare the addition of NMP-e to conventional physiotherapy versus conventional physiotherapy alone to see if the intervention provides additional benefits in gait rehabilitation and other functional outcomes. Participants will: * Continue their regular physiotherapy treatment consisting of passive and active-assisted mobilizations and strength exercises. * Receive NMP-e targeting the sciatic nerve at mid-thigh and the common peroneal nerve at the fibular head (exp

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Be between 18 and 70 years of age; 2. Have suffered a stroke (CVA); 3. Be in the subacute or chronic phase of the disease; 4. Be able to walk 10 meters without assistance from another person; 5. Currently be undergoing physiotherapy with conservative techniques; 6. Be able to understand the technique being applied; 7. Sign the informed consent form. Exclusion Criteria: 1. Belonephobia (fear of needles); 2. Allergy to needles or metals; 3. Presence of uncontrolled coagulopathies; 4. Presence of uncontrolled arterial disease; 5. Pregnancy; 6. Dermatological disorders; 7. Presence of diseases such as systemic inflammatory disorders (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or septic arthritis); 8. Presence of diseases such as tumors, cancer, or metastases; 9. Having received invasive physiotherapy treatment in the last 4 weeks.
💊

What it tests

  • Ultrasound-Guided Percutaneous Neuromodulation
📍

Where

1 site
Universidad de Zaragoza
Zaragoza, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy